John Rotrosen - Concepedia

Author

John Rotrosen

Also Known As

J P Rotrosen, J ROTROSEN, J Rotrosen, J. ROTROSEN, J. Rotrosen, JOHN P. ROTROSEN, JOHN ROTROSEN, John P Rotrosen, John P. Rotrosen, John Rotrosen

358

Publications

15K

Citations

H-Index

178

Concepts

All Affiliations

New York University VA NY Harbor Healthcare System Columbia University Irving Medical Center Columbia University Veterans Health Administration

About

John Rotrosen is an author at New York University specializing in medicine, psychiatry, and addiction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	122	8.7K
2	Health Sciences	28	46	3.1K
3	Education	4	4	291
4	Nursing	3	3	189
5	Engineering	1	1	22

John Rotrosen

198

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity Disorder F. Xavier Castellanos, Daniel S. Margulies, Clare Kelly, Biological Psychiatry NeuropsychologyBrain FunctionInhibitory ProcessAffective NeuroscienceCingulate-precuneus Interactions	2007	862
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial Joshua D. Lee, Edward V. Nunes, Patricia Novo, The Lancet Opioid EpidemicComparative EffectivenessSubstance AbuseOpioid Relapse PreventionAddiction Treatment	2017	681
Network homogeneity reveals decreased integrity of default-mode network in ADHD Lucina Q. Uddin, Clare Kelly, Bharat B. Biswal, Journal of Neuroscience Methods AdhdPsychiatryBehavioral NeuroscienceDefault-mode NetworkMedicine	2007	450
Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia Burt Angrist, John Rotrosen, Samuel Gershon Psychopharmacology Differential EffectsPsychopathologyPsychiatryPsychotic DisorderPsychotropic Medication	1980	343
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, New England Journal of Medicine	2016	310
Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography Adam Wolkin, Judith Jaeger, Jonathan D. Brodie, American Journal of Psychiatry Cerebral Metabolic AbnormalitiesNeuropsychiatryChronic SchizophreniaBrain LesionRelative Hyperactivity	1985	294
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff Jennifer McNeely, Pritika C. Kumar, Traci Rieckmann, Addiction Science & Clinical Practice	2018	282
Volumetric Measure of the Frontal and Temporal Lobe Regions in Schizophrenia Michael Sanfilipo, Todd Lafargue, Henry Rusinek, Archives of General Psychiatry	2000	279
Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia Adam Wolkin, F Barouche, A. P. Wolf, American Journal of Psychiatry NeuropsychologyPsychotropic MedicationPsychopharmacologyPharmacotherapySocial Sciences	1989	257
Reduced Interhemispheric Resting State Functional Connectivity in Cocaine Addiction Clare Kelly, Xi‐Nian Zuo, Kristin Gotimer, Biological Psychiatry Behavioral AddictionAddictionState Functional ConnectivityConnectomicsNeuroscience	2011	234

Page 1